Janssen Receives CHMP Positive Opinion for TREVICTA® (paliperidone palmitate a 3-monthly injection) Recommending Approval in the European Union for the Maintenance Treatment of Schizophrenia
- EMEA Innovative Medicine
- Janssen Receives CHMP Positive Opinion for TREVICTA® (paliperidone palmitate a 3-monthly injection) Recommending Approval in the European Union for the Maintenance Treatment of Schizophrenia
Janssen Receives CHMP Positive Opinion for TREVICTA® (paliperidone palmitate a 3-monthly injection) Recommending Approval in the European Union for the Maintenance Treatment of Schizophrenia
- X (Twitter)
Copy link